ABCL
AbCellera Biologics, Inc.
NASDAQ · Healthcare · Biotechnology · CA
$11.93
+1.10%Leverage
- Debt / equity
- 0.15x
- Net debt / equity
- 0.02x
- Debt / assets
- 0.10x
- Debt / EBITDA
- -0.80x
- Net debt / EBITDA
- -0.09x
Liquidity & coverage
- Current ratio
- 12.77x
- Quick ratio
- 12.63x
- Cash ratio
- 10.15x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $626.0M
Cash & dividend
- FCF / debt
- -1.32x
- Cash flow / debt
- -1.14x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026